SCHEMBL8346367

SCHEMBL8346367

COc1ccc(C=CC2=NN=C(C)Cc3cc(OC)c(OC)cc32)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.48
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CYP1A1 P04798 9/20 0.47
CYP1B1 Q16678 8/20 0.47
CYP1A2 P05177 3/20 0.47
TUBB4A P04350 1/20 0.47
TUBB P07437 1/20 0.47
TUBA3C P0DPH7 1/20 0.47
TUBA1B P68363 1/20 0.47
TUBA4A P68366 1/20 0.47
TUBB4B P68371 1/20 0.47
TUBB3 Q13509 1/20 0.47
TUBB2A Q13885 1/20 0.47
TUBB8 Q3ZCM7 1/20 0.47
TUBA3E Q6PEY2 1/20 0.47
TUBA1A Q71U36 1/20 0.47
TUBA1C Q9BQE3 1/20 0.47
TUBB6 Q9BUF5 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8346366 1.00 MAPT (0.48) MAPTALDH1A1HPGDSMN1; SMN2CYP1A1
SCHEMBL10479300 0.92 APP (0.49) MAPTCYP1A2NFE2L2PTGS2TTR
SCHEMBL10479299 0.92 APP (0.49) MAPTCYP1A2NFE2L2PTGS2TTR
SCHEMBL8005552 0.92 MAPT (0.40) MAPTALDH1A1HPGDSMN1; SMN2CYP1A1
SCHEMBL8005553 0.92 MAPT (0.40) MAPTALDH1A1HPGDSMN1; SMN2CYP1A1
SCHEMBL9069223 0.89 MAPK10 (0.43) MAPTALDH1A1HPGDSMN1; SMN2CYP1A1
SCHEMBL7993260 0.89 MAPT (0.44) MAPTALDH1A1HPGDSMN1; SMN2CYP1A1
SCHEMBL8343851 0.89 CYP19A1 (0.52) MAPTALDH1A1HPGDSMN1; SMN2CYP1A2
SCHEMBL7993262 0.89 MAPT (0.44) MAPTALDH1A1HPGDSMN1; SMN2CYP1A1
SCHEMBL8346996 0.89 TUBB4A (0.45) MAPTALDH1A1HPGDSMN1; SMN2CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5942506-A TREATMENT OF NERVOUS SYSTEM DISORDERS, ANXIETY GIS GYOGYSZERGYAR RT. (HU) 1999-08-24 US claimed
EP-0726257-A1 1-(Hetero)Arylvinyl-5H-2,3-benzodiazepine derivatives useful for the treatment of central nervous system disorders, and benzopyrylium intermediates for their preparation EGIS GYOGYSZERGYAR RT. (HU) 1996-08-14 EP claimed
US-5942506-A TREATMENT OF NERVOUS SYSTEM DISORDERS, ANXIETY GIS GYOGYSZERGYAR RT. (HU) 1999-08-24 US disclosed
EP-0726257-A1 1-(Hetero)Arylvinyl-5H-2,3-benzodiazepine derivatives useful for the treatment of central nervous system disorders, and benzopyrylium intermediates for their preparation EGIS GYOGYSZERGYAR RT. (HU) 1996-08-14 EP disclosed